Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bethmann

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical and Translational Radiation Oncology|March 30, 2018
P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patientsMatthias Kappler, Johanna Kotrba, Tom Kaune, et al.
Oncogene|March 11, 2021
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblastsMireia Berdiel-Acer, Ana Maia, Zhivka Hristova, et al.
BMC Cancer|February 17, 2019
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patientsSwetlana Rot, Tom Kaune, Helge Taubert, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer PatientsKathleen Schüler, Daniel Bethmann, Sandy Kaufhold, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Breast Care (Basel, Switzerland)|January 27, 2022
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular SubtypingCarolin Hartung, Martin Porsch, Kathrin Stückrath, et al.
NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical and Translational Radiation Oncology|March 30, 2018
P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patientsMatthias Kappler, Johanna Kotrba, Tom Kaune, et al.
Oncogene|March 11, 2021
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblastsMireia Berdiel-Acer, Ana Maia, Zhivka Hristova, et al.
BMC Cancer|February 17, 2019
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patientsSwetlana Rot, Tom Kaune, Helge Taubert, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer PatientsKathleen Schüler, Daniel Bethmann, Sandy Kaufhold, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Breast Care (Basel, Switzerland)|January 27, 2022
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular SubtypingCarolin Hartung, Martin Porsch, Kathrin Stückrath, et al.
NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.
Pageof 3